XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Net Loss Per Share
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Net Loss Per Share

Note 10 – Net Loss Per Share

 

The computations of basic and dilutive loss per share of commons stock outstanding for the three months ended March 31, 2025 and 2024 are as follows:

 

   Three Months Ended   Three Months Ended 
   March 31, 2025   March 31, 2024 
Net loss available to common shareholders  $(9,191,000)  $(2,367,000)
Basic and diluted weighted average of common stock outstanding   1,972,869    32,090 
Basic and diluted loss per common share   (4.66)   (73.76)

 

 

Algorhythm Holdings, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

March 31, 2025 and 2024 (Unaudited)

 

The computation of the fully diluted weighted average number of shares of common stock outstanding for the three months ended March 31, 2025 and 2024 is as follows:

  

   Three Months Ended   Three Months Ended 
   March 31, 2025   March 31, 2024 
Basic weighted average common shares outstanding   1,972,869    32,090 
Effect of dilutive stock options   -    - 
Diluted weighted average of common shares outstanding   1,972,869    32,090 

 

Basic net loss per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share reflects the potential dilution assuming shares of common stock underlying in-the-money options and warrants have been issued upon the exercise of the options and warrants and the proceeds thereof were used to purchase shares of the Company’s common stock at the average market price during the period using the treasury stock method.

 

For the three months ended March 31, 2025, 488 shares of common stock underlying stock options and 1,138,163 shares of common stock underlying warrants were excluded from the calculation of diluted net loss per share as the result would have been anti-dilutive. For the three months ended March 31, 2024, 454 shares of common stock underlying stock options and 4,511 shares of common stock underlying warrants were excluded from the calculation of diluted net loss per share as the result would have been anti-dilutive.